drugset
drugset / Trial / NCT04622735

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction

NCT04622735 ↗

Phase 3 Completed 321 enrolled Unither Pharmaceuticals, France Excelya · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the analgesic efficacy of single and multiple doses of a new fixed dose combination of nefopam hydrochloride 30 mg and paracetamol 500mg taken orally in comparison to each single component.

Timeline

Start
2020-02-22
Primary completion
2022-10-12
Completion
2022-10-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 500 mg Oral
Comparator Nefopam Small molecule 30 mg Oral

Indications

No indication recorded.